1. Home
  2. LEE vs AYTU Comparison

LEE vs AYTU Comparison

Compare LEE & AYTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lee Enterprises Incorporated

LEE

Lee Enterprises Incorporated

HOLD

Current Price

$4.65

Market Cap

22.9M

ML Signal

HOLD

Logo Aytu BioPharma Inc.

AYTU

Aytu BioPharma Inc.

HOLD

Current Price

$2.57

Market Cap

23.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LEE
AYTU
Founded
1890
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Newspapers/Magazines
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
22.9M
23.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
LEE
AYTU
Price
$4.65
$2.57
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$9.33
AVG Volume (30 Days)
58.9K
98.6K
Earning Date
02-05-2026
02-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$562,341,000.00
$63,696,000.00
Revenue This Year
$5.48
N/A
Revenue Next Year
N/A
$47.32
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.34
$0.95
52 Week High
$15.15
$2.82

Technical Indicators

Market Signals
Indicator
LEE
AYTU
Relative Strength Index (RSI) 64.26 64.74
Support Level $3.58 $2.42
Resistance Level $4.51 $2.59
Average True Range (ATR) 0.44 0.15
MACD 0.11 0.01
Stochastic Oscillator 59.24 87.50

Price Performance

Historical Comparison
LEE
AYTU

About LEE Lee Enterprises Incorporated

Lee Enterprises Inc is a local news publication company in the United States. It is a digital-first subscription business providing local markets with valuable, high-quality, trusted, intensely local news, information, advertising, and marketing services. The product portfolio of the company includes digital subscription platforms, daily, weekly, and monthly newspapers, and niche products, all delivering original local news and information as well as national and international news. The products offer digital and print editions, and content and advertising are available in real-time through the websites and mobile apps.

About AYTU Aytu BioPharma Inc.

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline, including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates one business segment consisting of various prescription pharmaceutical products sold through third parties.

Share on Social Networks: